New study confirms protective effect of diabetes drugs against kidney failure

A new meta-analysis published in The Lancet Diabetes and Endocrinology today has found that SGLT2 inhibitors can reduce the risk of dialysis, transplantation, or death due to kidney disease in people with type 2 diabetes.